Wilson, James;
(2022)
When does precision matter? Personalised medicine from the perspective of public health.
In: Barilan, Michael and Brusa, Margherita and Ciechanover, Aaron, (eds.)
Can precision medicine be personal; Can personalized medicine be precise?
(173-C13.N12).
Oxford University Press: Oxford, UK.
Preview |
Text
Wilson_When does precision matter_chapter_VoR.pdf Download (737kB) | Preview |
Abstract
This chapter examines the nature and value of precision in medicine, and in particular how precision medicine has been interpreted as favouring an ‘P4’ approach—one that is predictive, preventative, personalized, and participatory. It is argued that precision is a more controversial goal in medicine than is often acknowledged. A focus on precision will not always be easy to reconcile with other well-established health system goals, such as maximizing health benefit, improving health equity, or even avoiding iatrogenic harm. Given that precision approaches will often compete for resources with less targeted approaches, it is useful to ask how the model of predictive modelling and early intervention (secondary prevention) competes against rather less targeted interventions to improve the social determinants of health (primary prevention). The chapter argues that primary prevention is in general to be preferred to secondary prevention—both on grounds of equity and of cost-effectiveness—and to the extent that health systems end up cutting back on primary prevention to pursue precision medicine, they do their citizens a disservice.
| Type: | Book chapter |
|---|---|
| Title: | When does precision matter? Personalised medicine from the perspective of public health |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1093/oso/9780198863465.003.0013 |
| Publisher version: | https://doi.org/10.1093/oso/9780198863465.003.0013 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
| Keywords: | personalized medicine, health equity, cost-effectiveness, mass drug administration, public health ethics |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > UCL SLASH UCL > Provost and Vice Provost Offices > UCL SLASH > Faculty of Arts and Humanities UCL > Provost and Vice Provost Offices > UCL SLASH > Faculty of Arts and Humanities > Dept of Philosophy |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10117962 |
Archive Staff Only
 |
View Item |
